Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-10

FDA Approved: FENOFIBRATE — Original Application (Bostal LLC)

View source ↗

Summary

FDA approved the original application for fenofibrate by Bostal LLC, enabling the marketing of a generic fenofibrate product for lipid disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

ORIG AP for FENOFIBRATE (FENOFIBRATE)